Detection of CTCs postoperatively predict decreased disease‐free survival,16 while doing that preoperatively predict early recurrence and decreased disease‐free survival,17 and preoperative detection of KRAS‐mutated ctDNA is an independent risk factor for recurrence in CRC.18 Here, KRAS is linked to colorectal carcinoma.